Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours

European Journal of Nuclear Medicine

Volumn 23, Issue 3, 1996, Pages 308-311

  Maffioli, Lorenzo ^a   Gasparini, Massimo ^a   Chiti, Arturo ^a   Gramaglia, Alberto ^a   Mongioj, Valeria ^a   Pozzi, Annalisa ^b   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Brain tumour; Radiation necrosis; Relapse; Sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TOMOGRAPHY; BRAIN TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; RADIATION NECROSIS; RELAPSE; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; HUMANS; MIDDLE AGED; RECURRENCE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029969293     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00837629     Document Type: Article

References (12)

1. Valk PE, Dillon WP. Diagnostic imaging of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE, eds. Radiation injury to the central nervous system. New York: Raven Press; 1991: 211-237.
2. Muller ST, Guth-Tougelides B, Creutzig H. Imaging of malignant tumours with Tc-99m-MIBI SPECT. J Nucl Med 1987; 30: 845.
3. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis(alkylisonitrile) technetium-99m complexes. J Nucl Med 1990; 31: 1166-1167.
4. O'Tuama LA, Treves ST, Larar JN. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumours: a within-subject comparison. J Nucl Med 1993; 34: 1045-1051.
5. Macapinlac H, Scott A, Caluser C, et al. Comparison of TI-201 and Tc-99m-2-methoxy isobutyl isonitrile (MIBI) with MRI in the evaluation of recurrent brain tumors. J Nucl Med 1992; 33: 867.
6. Mountz JM, Rosenfeld SS, Li Y. Utility of T1-201 and Tc-99m-sestamibi SPECT for early determination of malignant tumor chemotherapy efficacy. J Nucl Med 1993; 34: 206P.
7. Kostakoglu L, Uzal D, Gülaldi N, Uysal U, Caner B, Aras T, Uǧur Ö, Bekdik CF. Detection of residual malignant brain tumors using Tc-99m-tetrofosmin: comparison with T1-201 and Tc-99m-sestamibi. Eur J Nucl Med 1995; 22: 867.
8. Gerundini P, Maffioli L. Cationic complexes of technetium for myocardial imaging. J Nucl Med 1989; 30: 1415-1419.
9. Savi A, Gerundini P, Zoli P, Maffioli L, Compierchio A, Colombo F, Matarrese M, Deutsch E. Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans. Eur J Nucl Med 1989; 15: 597-600.
10. Chiu M, Kronauge JF, Piwnica-Worms D, et al. Effect of mitochondrial and plasma-membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (1) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
11. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential-dependence. Circulation 1990; 82: 1826-1838.
12. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation of hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.